Latest Omnicell Inc (OMCL) Headlines
Shares of OMCL Up 19.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 07, 9:19AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 19.68% as of today's recent price of $28.82.
Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.
Vaica Announces SimpleMed+, its Next Generation Medication Adherence Management Solution for Chronically-ill and Hospital Discharged Patients
PR Newswire - Tue Feb 25, 9:21AM CST
Vaica today announced the commercial availability of SimpleMed+, the latest addition to its medication adherence and telehealth management platform. SimpleMed+ is a medication dispenser for use by patients who take a number of oral medications per day. Medications are loaded into the dispenser by a simple insertion of a standard pharmacy-prefilled multi-med blister packs, ensuring an error-free loading of the dispenser with a weekly supply of medications and alleviating the need for a nurse or a caregiver to assist or supervise the patient's medication intake process. SimpleMed+ currently supports standard multi-med blister packs made by MTS, a subsidiary of Omnicell (NASDAQ: OMCL), with support for other brands of multi-med blister packs to follow soon. SimpleMed+ is also a telehealth hub that collects and uploads the patient's vital signs data directly into the patient's cloud-based EHR. It has an integrated NFC reader for home-care workforce timesheet management, and a QR code reader for the transfer of blister-specific information. SimpleMed+ connects with Vaica's cloud service via its built-in cellular communications device or via Qualcomm's 2net.
Omnicell To Present At The Cowen And Company 34th Annual Health Care Conference
PR Newswire - Tue Feb 25, 7:00AM CST
Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the Cowen and Company 34th Annual Health Care Conference at the Boston Marriott Copley Place in Boston, MA.
Omnicell Introduces OptiFlex 12.0 for Improved Supply Inventory Management with Unique Device Identification
PR Newswire - Mon Feb 24, 12:57PM CST
Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for health care providers, today announced OptiFlex(TM) 12.0 to improve supply management throughout health care facilities. The newest version of OptiFlex includes automated unique device identification (UDI) capabilities that seamlessly integrate into Omnicell's end-to-end supply management solution.
Merge Posts Q4 Earnings, Revs Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 8:00AM CST
Merge Healthcare reported fourth-quarter 2013 adjusted net income per share of 3 cents.
Omnicell to Showcase Benefits of Interoperability and Clinical Analytics at HIMSS 2014 Conference
PR Newswire - Mon Feb 24, 7:00AM CST
As part of HIMSS 2014, Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, will showcase the interoperability of its automated dispensing systems in the HIMSS Interoperability Showcase and the Intelligent Hospital(TM) Pavilion along with partner collaborations and customer presentations across the exhibition floor.
Allscripts Healthcare Solutions Earnings Continue to Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 12:00PM CST
On a reported basis, MDRX incurred a loss of $20.6 million or 12 cents per share compared with $24.3 million or 14 cents in the fourth quarter of 2012 due to flat revenues and higher selling, general and administrative expenses.
Omnicell Has Returned 15.0% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Thu Feb 20, 11:13AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 3 months, Omnicell has returned 15.03% as of today's recent price of $27.70.
Quality Systems Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 2:30PM CST
On Feb 19, Zacks Investment Research downgraded Quality Systems to a Zacks Rank #5 (Strong Sell).
Surging Rank, Surging Stock; Why Computer Programs & Systems (CPSI) Is a Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 7:34AM CST
One company that should be on your radar is Computer Programs & Systems , whose stock has seen its Zacks Rank surge over the past four weeks, moving from Hold to Strong Buy.
Spredfast Expands Operations in Europe
PR Newswire - Wed Feb 12, 11:01PM CST
Spredfast, the leading independent social relationship platform, today announced its entrance into Europe with the opening of its first office in the United Kingdom. Among the more than 300 enterprise brands that choose Spredfast to manage their strategic social programs, many are already running social operations on a global level. Currently the company serves customers in more than 20 different countries including British Airways, Vodafone UK, and Reed Business Information - UK. Now with a U.K. hub in London, Spredfast will be able to support the increasing demand from international brands and further its global expansion efforts.
Concise Analysis of the International Medical Automation Market - Forecasts to 2018
M2 - Wed Feb 12, 5:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/c64v2t/medical) has announced the addition of the "Concise Analysis of the International Medical Automation Market - Forecasts to 2018" report to their offering. The global medical automation market is valued at $43,213.6 million in 2013. The medical automation market is broadly classified on the basis of application, end-users, and geography. The applications market is further divided into diagnostics and monitoring automation, therapeutic automation, lab and pharmacy automation, and logistics and training automation. Under therapeutic automation, the surgical automation market showcases a lucrative growth potential. Surgical robots, intelligent operating rooms, and surgical simulators represent the new revenue pockets and are expected to flourish in future. The need for reproducibility and accuracy in medical procedures, rising labor costs, government and venture capitalist investments, are the factors that are likely to provide an impetus for the growth of the medical automation market in future. However, varied stringency of regulatory procedures globally, and an implementation of 2.3% tax by the U.S. government on medical devices manufacturers is likely to hinder the growth of this market. Despite this, the presence of an untapped market in emerging countries, the increasing number of collaborations between healthcare automation companies and research institutes to promote research, and the growing need of automation in various other medical fields such as genomics and proteomics represents the growth opportunities for this market. The global medical automation market is highly competitive and all the existing players in this market are engaged in developing new and advanced products, to maintain their market share. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Diagnostics & Monitoring Automation Market 5 Global Therapeutic Automation Market 6 Lab & Pharmacy Automation Market 7 Medical Logistics & Training Automation Market 8 Global Medical Automation Market, By End User 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles Companies Mentioned: - Accuray - Asahi Kasei - Awarepoint - Beckman Coulter - Brainlab - CAE - Carefusion - Carl Zeiss - Ekahau - GE Healthcare - Given Imaging - ICAD - Intuitive Surgical - Laerdal Medical - Lifescan - Medtronic - Moog - Omnicell - Omron - Parata Systems - Philips Healthcare - Roche Holding - Siemens Healthcare - Simsurgery - St Jude Medical - Stanley Black and Decker - Stryker - Swisslog Holdings - Tecan Group For more information visit http://www.researchandmarkets.com/research/c64v2t/medical
Omnicell Misses on Q4 Earnings, Beats Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 9:10AM CST
Omnicell reported its fourth quarter and full-year 2013 financial results.
athenahealth Earnings Beat, Rise More than Twofold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 9:00AM CST
Excluding the Epocrates and other revenues (consisting of third-party tenant revenues) totaling $22.6 million, core athenahealth revenues rose 28% to $149.0 million in the quarter.
13.4% Return Seen to Date on SmarTrend Omnicell Call (OMCL)
Comtex SmarTrend(R) - Thu Feb 06, 9:21AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 3 months, Omnicell has returned 13.37% as of today's recent price of $27.30.
Why Omnicell Inc. Shares Popped
Alex Planes, The Motley Fool - Motley Fool - Wed Feb 05, 12:28PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Omnicell rose by as much as 15% at the...
Nasdaq stocks posting largest percentage increases
AP - Wed Feb 05, 12:20PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
Shares of OMCL Up 19.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 07, 9:19AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 19.68% as of today's recent price of $28.82.
Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.
Vaica Announces SimpleMed+, its Next Generation Medication Adherence Management Solution for Chronically-ill and Hospital Discharged Patients
PR Newswire - Tue Feb 25, 9:21AM CST
Vaica today announced the commercial availability of SimpleMed+, the latest addition to its medication adherence and telehealth management platform. SimpleMed+ is a medication dispenser for use by patients who take a number of oral medications per day. Medications are loaded into the dispenser by a simple insertion of a standard pharmacy-prefilled multi-med blister packs, ensuring an error-free loading of the dispenser with a weekly supply of medications and alleviating the need for a nurse or a caregiver to assist or supervise the patient's medication intake process. SimpleMed+ currently supports standard multi-med blister packs made by MTS, a subsidiary of Omnicell (NASDAQ: OMCL), with support for other brands of multi-med blister packs to follow soon. SimpleMed+ is also a telehealth hub that collects and uploads the patient's vital signs data directly into the patient's cloud-based EHR. It has an integrated NFC reader for home-care workforce timesheet management, and a QR code reader for the transfer of blister-specific information. SimpleMed+ connects with Vaica's cloud service via its built-in cellular communications device or via Qualcomm's 2net.
Omnicell To Present At The Cowen And Company 34th Annual Health Care Conference
PR Newswire - Tue Feb 25, 7:00AM CST
Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the Cowen and Company 34th Annual Health Care Conference at the Boston Marriott Copley Place in Boston, MA.
Omnicell Introduces OptiFlex 12.0 for Improved Supply Inventory Management with Unique Device Identification
PR Newswire - Mon Feb 24, 12:57PM CST
Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for health care providers, today announced OptiFlex(TM) 12.0 to improve supply management throughout health care facilities. The newest version of OptiFlex includes automated unique device identification (UDI) capabilities that seamlessly integrate into Omnicell's end-to-end supply management solution.
Merge Posts Q4 Earnings, Revs Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 8:00AM CST
Merge Healthcare reported fourth-quarter 2013 adjusted net income per share of 3 cents.
Omnicell to Showcase Benefits of Interoperability and Clinical Analytics at HIMSS 2014 Conference
PR Newswire - Mon Feb 24, 7:00AM CST
As part of HIMSS 2014, Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, will showcase the interoperability of its automated dispensing systems in the HIMSS Interoperability Showcase and the Intelligent Hospital(TM) Pavilion along with partner collaborations and customer presentations across the exhibition floor.
Allscripts Healthcare Solutions Earnings Continue to Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 12:00PM CST
On a reported basis, MDRX incurred a loss of $20.6 million or 12 cents per share compared with $24.3 million or 14 cents in the fourth quarter of 2012 due to flat revenues and higher selling, general and administrative expenses.
Omnicell Has Returned 15.0% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Thu Feb 20, 11:13AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 3 months, Omnicell has returned 15.03% as of today's recent price of $27.70.
Quality Systems Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 2:30PM CST
On Feb 19, Zacks Investment Research downgraded Quality Systems to a Zacks Rank #5 (Strong Sell).
Surging Rank, Surging Stock; Why Computer Programs & Systems (CPSI) Is a Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 7:34AM CST
One company that should be on your radar is Computer Programs & Systems , whose stock has seen its Zacks Rank surge over the past four weeks, moving from Hold to Strong Buy.
Spredfast Expands Operations in Europe
PR Newswire - Wed Feb 12, 11:01PM CST
Spredfast, the leading independent social relationship platform, today announced its entrance into Europe with the opening of its first office in the United Kingdom. Among the more than 300 enterprise brands that choose Spredfast to manage their strategic social programs, many are already running social operations on a global level. Currently the company serves customers in more than 20 different countries including British Airways, Vodafone UK, and Reed Business Information - UK. Now with a U.K. hub in London, Spredfast will be able to support the increasing demand from international brands and further its global expansion efforts.
Concise Analysis of the International Medical Automation Market - Forecasts to 2018
M2 - Wed Feb 12, 5:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/c64v2t/medical) has announced the addition of the "Concise Analysis of the International Medical Automation Market - Forecasts to 2018" report to their offering. The global medical automation market is valued at $43,213.6 million in 2013. The medical automation market is broadly classified on the basis of application, end-users, and geography. The applications market is further divided into diagnostics and monitoring automation, therapeutic automation, lab and pharmacy automation, and logistics and training automation. Under therapeutic automation, the surgical automation market showcases a lucrative growth potential. Surgical robots, intelligent operating rooms, and surgical simulators represent the new revenue pockets and are expected to flourish in future. The need for reproducibility and accuracy in medical procedures, rising labor costs, government and venture capitalist investments, are the factors that are likely to provide an impetus for the growth of the medical automation market in future. However, varied stringency of regulatory procedures globally, and an implementation of 2.3% tax by the U.S. government on medical devices manufacturers is likely to hinder the growth of this market. Despite this, the presence of an untapped market in emerging countries, the increasing number of collaborations between healthcare automation companies and research institutes to promote research, and the growing need of automation in various other medical fields such as genomics and proteomics represents the growth opportunities for this market. The global medical automation market is highly competitive and all the existing players in this market are engaged in developing new and advanced products, to maintain their market share. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Diagnostics & Monitoring Automation Market 5 Global Therapeutic Automation Market 6 Lab & Pharmacy Automation Market 7 Medical Logistics & Training Automation Market 8 Global Medical Automation Market, By End User 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles Companies Mentioned: - Accuray - Asahi Kasei - Awarepoint - Beckman Coulter - Brainlab - CAE - Carefusion - Carl Zeiss - Ekahau - GE Healthcare - Given Imaging - ICAD - Intuitive Surgical - Laerdal Medical - Lifescan - Medtronic - Moog - Omnicell - Omron - Parata Systems - Philips Healthcare - Roche Holding - Siemens Healthcare - Simsurgery - St Jude Medical - Stanley Black and Decker - Stryker - Swisslog Holdings - Tecan Group For more information visit http://www.researchandmarkets.com/research/c64v2t/medical
Omnicell Misses on Q4 Earnings, Beats Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 9:10AM CST
Omnicell reported its fourth quarter and full-year 2013 financial results.
athenahealth Earnings Beat, Rise More than Twofold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 9:00AM CST
Excluding the Epocrates and other revenues (consisting of third-party tenant revenues) totaling $22.6 million, core athenahealth revenues rose 28% to $149.0 million in the quarter.
13.4% Return Seen to Date on SmarTrend Omnicell Call (OMCL)
Comtex SmarTrend(R) - Thu Feb 06, 9:21AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 3 months, Omnicell has returned 13.37% as of today's recent price of $27.30.
Why Omnicell Inc. Shares Popped
Alex Planes, The Motley Fool - Motley Fool - Wed Feb 05, 12:28PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Omnicell rose by as much as 15% at the...
Nasdaq stocks posting largest percentage increases
AP - Wed Feb 05, 12:20PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
